These suggest that during the development of NSCLC, lower SLC7A2 expression may change the levels of chemokines to reshape immune landscape in NSCLC to promote its growth and immune escape and modulate its chemoresistance. The gene discussed is SLC7A2; the disease is non-small cell lung carcinoma.